Aspect Biosystems Revenue and Competitors
Estimated Revenue & Valuation
- Aspect Biosystems's estimated annual revenue is currently $18M per year.
- Aspect Biosystems received $2.7M in venture funding in November 2018.
- Aspect Biosystems's estimated revenue per employee is $170,000
- Aspect Biosystems's total funding is $24M.
Employee Data
- Aspect Biosystems has 106 Employees.
- Aspect Biosystems grew their employee count by 20% last year.
Aspect Biosystems Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.3M | 61 | 0% | N/A | N/A |
#2 | $1.9M | 19 | 0% | N/A | N/A |
#3 | $2.7M | 23 | 10% | N/A | N/A |
#4 | $3.5M | 29 | 4% | N/A | N/A |
#5 | $1.8M | 18 | 6% | N/A | N/A |
#6 | $1.8M | 18 | 6% | N/A | N/A |
#7 | $3.1M | 26 | 8% | N/A | N/A |
#8 | $1.1M | 11 | -8% | N/A | N/A |
#9 | $0.5M | 6 | -25% | N/A | N/A |
#10 | $1M | 10 | 0% | N/A | N/A |
What Is Aspect Biosystems?
Aspect Biosystems Ltd. is a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering. The company's proprietary Lab-on-a-Printer platform technology is enabling advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine. In addition to its internal programs, Aspect is focused on strategically partnering with pharmaceutical and biotechnology companies, as well as academic researchers, to create physiologically and commercially relevant tissues. These tissues are used to advance and accelerate the discovery and development of new drugs and therapies.
keywords:N/A
$24M
Total Funding
106
Number of Employees
$18M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Aspect Biosystems's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Scientific Officer at Aspect Biosystems Ltd. | Reveal Email/Phone |
2 | Research Scientist | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | Lead Software Engineer | Reveal Email/Phone |
5 | Research Scientist | Reveal Email/Phone |
6 | Founder & CEO | Reveal Email/Phone |
7 | Chief Scientific Officer at Aspect Biosystems | Reveal Email/Phone |
Aspect Biosystems News
Aspect Biosystems Announces Partnership with JDRF to Advance ... PR Newswire
Aspect Biosystems Partners With JDRF to Treat Diabetes 3DPrint.com
Aspect Biosystems and JDRF to develop 3D bioprinted treatment for ... 3D Printing Industry
Aspect Biosystems, a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, announced it raised $20 million in Series A Aspect Biosystems — a biotechnology company pioneering microfluidic 3D bioprinting of human tissues — announced recently that it raised $20 million in ...
Aspect’s broadly applicable technology platform enables the creation of living human tissues with unprecedented control, flexibility, and precision. In addition to Aspect’s internal tissue therapeutic programs for regenerative medicine, the Company works with its global partners to create high-v ...
Other Companies in Vancouver
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.8M | 106 | -39% | N/A |
#2 | $35M | 106 | 7% | N/A |
#3 | $24.1M | 106 | 5% | N/A |
#4 | $28.6M | 106 | -5% | N/A |
#5 | $28.6M | 106 | 86% | N/A |
Aspect Biosystems Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2017-09-21 | $Undisclosed | Undisclosed | Pangaea Ventures | Article |
| 2018-05-08 | $1.0M | Undisclosed | Genome British Columbia | Article |
| 2018-11-16 | $2.7M | Undisclosed | Western Innovation (WINN) Initiative. | Article |